BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18596699)

  • 1. Novel type of Ras effector interaction established between tumour suppressor NORE1A and Ras switch II.
    Stieglitz B; Bee C; Schwarz D; Yildiz O; Moshnikova A; Khokhlatchev A; Herrmann C
    EMBO J; 2008 Jul; 27(14):1995-2005. PubMed ID: 18596699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Growth and tumor suppressor NORE1A is a regulatory node between Ras signaling and microtubule nucleation.
    Bee C; Moshnikova A; Mellor CD; Molloy JE; Koryakina Y; Stieglitz B; Khokhlatchev A; Herrmann C
    J Biol Chem; 2010 May; 285(21):16258-66. PubMed ID: 20339001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of interactions of adapter protein RAPL/Nore1B with RAP GTPases and their role in T cell migration.
    Miertzschke M; Stanley P; Bunney TD; Rodrigues-Lima F; Hogg N; Katan M
    J Biol Chem; 2007 Oct; 282(42):30629-42. PubMed ID: 17716979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineered variants of the Ras effector protein RASSF5 (NORE1A) promote anticancer activities in lung adenocarcinoma.
    Singh A; Erijman A; Noronha A; Kumar H; Peleg Y; Yarden Y; Shifman JM
    J Biol Chem; 2021 Dec; 297(6):101353. PubMed ID: 34717958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras regulates SCF(β-TrCP) protein activity and specificity via its effector protein NORE1A.
    Schmidt ML; Donninger H; Clark GJ
    J Biol Chem; 2014 Nov; 289(45):31102-10. PubMed ID: 25217643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nore1 and RASSF1 regulation of cell proliferation and of the MST1/2 kinases.
    Avruch J; Praskova M; Ortiz-Vega S; Liu M; Zhang XF
    Methods Enzymol; 2006; 407():290-310. PubMed ID: 16757333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The growth and tumor suppressor NORE1A is a cytoskeletal protein that suppresses growth by inhibition of the ERK pathway.
    Moshnikova A; Frye J; Shay JW; Minna JD; Khokhlatchev AV
    J Biol Chem; 2006 Mar; 281(12):8143-52. PubMed ID: 16421102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of the NORE1A tumor suppressor in Oncogene-Induced Senescence.
    Barnoud T; Schmidt ML; Donninger H; Clark GJ
    Cancer Lett; 2017 Aug; 400():30-36. PubMed ID: 28455242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structure of M-Ras reveals a GTP-bound "off" state conformation of Ras family small GTPases.
    Ye M; Shima F; Muraoka S; Liao J; Okamoto H; Yamamoto M; Tamura A; Yagi N; Ueki T; Kataoka T
    J Biol Chem; 2005 Sep; 280(35):31267-75. PubMed ID: 15994326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dynamic mechanism of RASSF5 and MST kinase activation by Ras.
    Liao TJ; Jang H; Tsai CJ; Fushman D; Nussinov R
    Phys Chem Chem Phys; 2017 Mar; 19(9):6470-6480. PubMed ID: 28197608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ras Regulates Rb via NORE1A.
    Barnoud T; Donninger H; Clark GJ
    J Biol Chem; 2016 Feb; 291(6):3114-23. PubMed ID: 26677227
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic characterization of apoptotic Ras signaling through Nore1-MST1 complex formation.
    Koturenkiene A; Makbul C; Herrmann C; Constantinescu-Aruxandei D
    Biol Chem; 2017 May; 398(5-6):701-707. PubMed ID: 28141542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NORE1A directs apoptotic switch of TNF signaling through reciprocal modulation of ITCH-mediated destruction of TNFRI and BAX.
    Ko KP; Jeong SI; Lim JS; Lee KW; Lee MG; Chi SG
    Oncogene; 2020 Aug; 39(34):5675-5689. PubMed ID: 32690868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NORE1A tumor suppressor candidate modulates p21CIP1 via p53.
    Calvisi DF; Donninger H; Vos MD; Birrer MJ; Gordon L; Leaner V; Clark GJ
    Cancer Res; 2009 Jun; 69(11):4629-37. PubMed ID: 19435914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ras signaling through RASSF proteins.
    Donninger H; Schmidt ML; Mezzanotte J; Barnoud T; Clark GJ
    Semin Cell Dev Biol; 2016 Oct; 58():86-95. PubMed ID: 27288568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of apoptosis by NORE1A in a manner dependent on its nuclear export.
    Park SJ; Lee D; Choi CY; Ryu SY
    Biochem Biophys Res Commun; 2008 Mar; 368(1):56-61. PubMed ID: 18211824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners.
    Rezaei Adariani S; Kazemein Jasemi NS; Bazgir F; Wittich C; Amin E; Seidel CAM; Dvorsky R; Ahmadian MR
    J Biol Chem; 2021; 296():100626. PubMed ID: 33930461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The growth and tumor suppressors NORE1A and RASSF1A are targets for calpain-mediated proteolysis.
    Kuznetsov S; Khokhlatchev AV
    PLoS One; 2008; 3(12):e3997. PubMed ID: 19098985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural basis for the unique biological function of small GTPase RHEB.
    Yu Y; Li S; Xu X; Li Y; Guan K; Arnold E; Ding J
    J Biol Chem; 2005 Apr; 280(17):17093-100. PubMed ID: 15728574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The RAS-Effector Interface: Isoform-Specific Differences in the Effector Binding Regions.
    Nakhaeizadeh H; Amin E; Nakhaei-Rad S; Dvorsky R; Ahmadian MR
    PLoS One; 2016; 11(12):e0167145. PubMed ID: 27936046
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.